Pfizer’s Emblaveo gets EC approval for treatment of multidrug-resistant infections
Pfizer’s Emblaveo (aztreonam-avibactam) has secured marketing authorisation from the European Commission (EC) for the treatment of adult patients with multidrug-resistant infections and who have limited treatment options. The